rs121918114
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_004320.6(ATP2A1):c.2025C>A(p.Cys675*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000144 in 1,461,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004320.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Brody myopathyInheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004320.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP2A1 | NM_004320.6 | MANE Select | c.2025C>A | p.Cys675* | stop_gained | Exon 15 of 23 | NP_004311.1 | ||
| ATP2A1 | NM_173201.5 | c.2025C>A | p.Cys675* | stop_gained | Exon 15 of 22 | NP_775293.1 | |||
| ATP2A1 | NM_001286075.2 | c.1650C>A | p.Cys550* | stop_gained | Exon 13 of 21 | NP_001273004.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP2A1 | ENST00000395503.9 | TSL:1 MANE Select | c.2025C>A | p.Cys675* | stop_gained | Exon 15 of 23 | ENSP00000378879.5 | ||
| ATP2A1 | ENST00000357084.7 | TSL:2 | c.2025C>A | p.Cys675* | stop_gained | Exon 15 of 22 | ENSP00000349595.3 | ||
| ATP2A1 | ENST00000536376.5 | TSL:2 | c.1650C>A | p.Cys550* | stop_gained | Exon 13 of 21 | ENSP00000443101.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000803 AC: 2AN: 249188 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461872Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Brody myopathy Pathogenic:4
This sequence change creates a premature translational stop signal (p.Cys675*) in the ATP2A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATP2A1 are known to be pathogenic (PMID: 8841193, 10914677, 23911890). This variant is present in population databases (rs121918114, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with Brody myopathy (PMID: 8841193). ClinVar contains an entry for this variant (Variation ID: 17803). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at